Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63875 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Aishwarya Selvaraman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, B…. Hauptthemen laut MEDLINE: Oxidoreductases Acting on CH-CH Group Donors, Smith-Lemli-Opitz Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Intramural Research Program.
Abstract (Originalsprache)
Smith–Lemli–Opitz syndrome (SLOS) is a rare autosomal recessive disorder caused by pathological variants in DHCR7 , resulting in a deficiency in the enzyme 7‐dehydrocholesterol reductase. This results in elevated levels of cholesterol precursors and typically low cholesterol levels, leading to a range of physical and cognitive challenges. Mortality rates in infants with severe SLOS are high, due to congenital malformations. Premature death has been described in individuals with SLOS, particularly in severely affected individuals. Further research is needed to understand postnatal mortality risk factors for individuals with SLOS. Understanding these factors could improve monitoring and prevention efforts. To investigate this, we obtained death certificates from the National Death Index (NDI) database on a cohort of individuals with SLOS who were enrolled in natural history studies at the National Institutes of Health Clinical Center (NCT00001721 and NCT05047354). Analysis and comparison of this deceased cohort showed that although premature death occurs in SLOS, many individuals with SLOS survive into adulthood. We also observed the risk of postnatal mortality increasing with higher severity scores and lower initial cholesterol levels. Trial Registration: NCT00001721 and NCT05047354.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Forbes D Porter
Förderung
- Intramural NIH HHS
- Intramural Research Program
Zitieren
APA
Selvaraman, A., Rahhal, S., Bianconi, S., Furnary, T., & Porter, F. D. (2025). Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63875
Vancouver
Selvaraman A, Rahhal S, Bianconi S, Furnary T, Porter FD. Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63875
BibTeX
@article{Selvaraman2025,
author = {Selvaraman, Aishwarya and Rahhal, Samar and Bianconi, Simona and Furnary, Tristan and Porter, Forbes D},
title = {Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63875}
}
EUVIMED